Vero Cells
-
Subject Areas on Research
- A Chlamydia effector combining deubiquitination and acetylation activities induces Golgi fragmentation.
- A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation.
- A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus.
- ADAP2 Is an Interferon Stimulated Gene That Restricts RNA Virus Entry.
- ATM binds to beta-adaptin in cytoplasmic vesicles.
- Acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty.
- African and Asian strains of Zika virus differ in their ability to infect and lyse primitive human placental trophoblast.
- An Evolutionary Insertion in the Mxra8 Receptor-Binding Site Confers Resistance to Alphavirus Infection and Pathogenesis.
- Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia.
- Antiviral Effect of Retro-2.1 against Herpes Simplex Virus Type 2 In Vitro.
- Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo.
- Attenuation of herpes simplex virus neurovirulence with picornavirus cis-acting genetic elements.
- Chimeric Sindbis/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice.
- Chimeric alphavirus vaccine candidates for chikungunya.
- Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.
- Clinical isolates of measles virus use CD46 as a cellular receptor.
- Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine.
- Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CLpro Reporter Assay.
- Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120.
- Environmental and Aerosolized Severe Acute Respiratory Syndrome Coronavirus 2 Among Hospitalized Coronavirus Disease 2019 Patients.
- Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays.
- Forward and Reverse Genetic Analysis of Chlamydia.
- Generation of recombinant vaccinia virus and analysis of virus-induced cell death.
- Genome nucleotide lengths that are divisible by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus simian virus 5.
- Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid.
- Glycoprotein B of human herpesvirus 8 is a component of the virion in a cleaved form composed of amino- and carboxyl-terminal fragments.
- Glycosaminoglycan binding properties of natural venezuelan equine encephalitis virus isolates.
- ICP34.5-dependent and -independent activities of salubrinal in herpes simplex virus-1 infected cells.
- Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine.
- Interferon Inhibition Enhances the Pilot-Scale Production of Rabies Virus in Human Diploid MRC-5 Cells.
- Lipid A Has Significance for Optimal Growth of Coxiella burnetii in Macrophage-Like THP-1 Cells and to a Lesser Extent in Axenic Media and Non-phagocytic Cells.
- Lipid and Nucleocapsid N-Protein Accumulation in COVID-19 Patient Lung and Infected Cells.
- Modeling of variables in cellular infection reveals CXCL10 levels are regulated by human genetic variation and the Chlamydia-encoded CPAF protease.
- Modulation of murine herpes simplex virus type 1 retinitis in the uninoculated eye by CD4+ T lymphocytes.
- N-Acylated Derivatives of Sulfamethoxazole Block Chlamydia Fatty Acid Synthesis and Interact with FabF.
- OPTN is a host intrinsic restriction factor against neuroinvasive HSV-1 infection.
- Ochratoxin A-induced cytotoxicity, genotoxicity and reactive oxygen species in kidney cells: An integrative approach of complementary endpoints.
- Post-transcriptional regulation of antiviral gene expression by N6-methyladenosine.
- Reassessing the role of the secreted protease CPAF in Chlamydia trachomatis infection through genetic approaches.
- Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector.
- Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques.
- SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.
- SARS-CoV-2 triggers DNA damage response in Vero E6 cells.
- Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network.
- TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2.
- The Chlamydia trachomatis Inclusion Membrane Protein CpoS Counteracts STING-Mediated Cellular Surveillance and Suicide Programs.
- The small GTPase RAB1B promotes antiviral innate immunity by interacting with TNF receptor-associated factor 3 (TRAF3).
- The stimulation of cellular phospholipid uptake by surfactant apoproteins.
- Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus Infection.
- Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus.
- Virulence and viremia characteristics of 1992 epizootic subtype IC Venezuelan equine encephalitis viruses and closely related enzootic subtype ID strains.
-
Keywords of People
- Luftig, Micah Alan, Professor of Molecular Genetics and Microbiology, Cell Biology